Research ArticleRESEARCH ARTICLE
Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;
B. Nuijen
M. Bouma
R. E. C. Henrar
P. Floriano
J. M. Jimeno
H. Talsma
J. J. Kettenes-van den Bosch
A. J. R. Heck
A. Bult
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 54, Issue 3
May/June 2000
Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult, J. H. Beijnen
PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;
Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult, J. H. Beijnen
PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;
Jump to section
Related Articles
- No related articles found.
Cited By...
More in this TOC Section
Similar Articles